S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69

Coronavirus Stocks

Below you will find a list of companies that have had the highest percentage gains and losses since coronavirus (COVID-19) became a major issue in the United States, which was approximately March 1st, 2020. Learn more on coronavirus stock.

MarketRank evaluates a company based on community opinion, dividend strength, institutional and insider ownership, earnings and valuation, and analysts forecasts.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyYesterday's ClosePrice on March 1st, 2020Price ChangeConsensus RatingPrice TargetIndicator(s)
MIG
VanEck Vectors Moody's Analytics IG Corporate Bond ETF
$24.18$0.10+25,348.9%N/A
ISIG
Insignia Systems
$17.60$0.11+15,900.0%N/AGap Down
ACET
Adicet Bio
$11.93$0.11+10,292.0%Buy$32.60
RMBL
RumbleON
$33.81$0.34+9,771.5%Buy$58.80Analyst Upgrade
News Coverage
CERE
Cerevel Therapeutics
$25.29$0.40+6,270.3%Buy$45.20
NBR
Nabors Industries
$99.01$1.76+5,525.6%Hold$105.00
RZLT
Rezolute
$4.42$0.09+4,704.3%Buy$21.25Positive News
High Trading Volume
WLL
Whiting Petroleum
$71.55$1.85+3,767.6%Buy$77.00Analyst Report
News Coverage
GME
GameStop
$106.36$3.60+2,854.4%Sell$73.67
VRME
VerifyMe
$3.05$0.10+2,832.7%N/A
MARA
Marathon Digital
$22.06$0.86+2,465.4%Buy$55.80Analyst Report
Analyst Revision
Gap Down
SUMR
Summer Infant
$10.04$0.44+2,170.3%N/A
IPI
Intrepid Potash
$37.53$1.77+2,020.3%Hold$32.33News Coverage
CPE
Callon Petroleum
$47.23$2.27+1,980.6%Hold$60.00Analyst Downgrade
Analyst Revision
News Coverage
Gap Down
RENN
Renren
$21.74$1.29+1,591.8%N/AShort Interest ↑
DAC
Danaos
$78.12$5.04+1,450.0%Buy$89.00Analyst Report
Analyst Revision
News Coverage
APVO
Aptevo Therapeutics
$5.89$0.43+1,269.8%Buy$36.00Short Interest ↓
News Coverage
Gap Down
PTSI
P.A.M. Transportation Services
$67.70$4.95+1,267.3%HoldNews Coverage
KIRK
Kirkland's
$15.38$1.18+1,203.4%Buy$35.00
GOVX
GeoVax Labs
$2.43$0.20+1,115.0%Buy$10.00Short Interest ↑
News Coverage
MVIS
MicroVision
$3.08$0.25+1,111.6%Hold
AMTX
Aemetis
$8.89$0.74+1,100.8%Buy$29.25Short Interest ↑
Gap Down
USAU
U.S. Gold
$7.34$0.63+1,072.3%Buy$20.50
JAKK
JAKKS Pacific
$8.18$0.71+1,058.0%N/AInsider Selling
Short Interest ↑
ESEA
Euroseas
$25.78$2.41+968.6%Buy$40.00Short Interest ↓
Gap Down
AR
Antero Resources
$16.97$1.60+960.6%Buy$23.80Analyst Upgrade
CLDX
Celldex Therapeutics
$27.87$2.63+959.7%Buy$59.00
SURG
SurgePays
$3.07$0.30+940.7%N/AInsider Buying
KOPN
Kopin
$3.17$0.32+903.2%Buy
BLNK
Blink Charging
$20.98$2.27+824.2%Buy$38.50Analyst Upgrade
Gap Down
ICD
Independence Contract Drilling
$3.45$0.40+773.0%N/ANews Coverage
Gap Down
SITM
SiTime
$195.51$22.66+762.8%Buy$312.00Analyst Downgrade
Insider Selling
ACRS
Aclaris Therapeutics
$9.74$1.14+754.4%Buy$36.00
NTZ
Natuzzi
$12.01$1.41+751.8%N/AShort Interest ↓
News Coverage
High Trading Volume
NVNO
enVVeno Medical
$5.80$0.69+743.5%N/ANews Coverage
High Trading Volume
BGFV
Big 5 Sporting Goods
$18.53$2.23+730.9%Buy$31.00
VMW
VMware
$123.74$15.00+724.9%Buy$155.78Analyst Report
News Coverage
EKSO
Ekso Bionics
$2.42$0.30+710.4%Buy$11.00Short Interest ↓
News Coverage
CELH
Celsius
$43.92$5.91+643.1%Buy$107.60Gap Down
VRTV
Veritiv
$89.11$12.04+640.1%Buy$86.00
KOSS
Koss
$8.74$1.19+634.1%N/AUpcoming Earnings
OCGN
Ocugen
$3.28$0.45+628.9%Hold$7.90News Coverage
Gap Down
SBOW
SilverBow Resources
$20.32$2.81+623.1%Buy$39.00Analyst Downgrade
Short Interest ↑
TSLA
Tesla
$943.90$132.87+610.4%Hold$896.76Upcoming Earnings
Analyst Report
Insider Selling
Analyst Revision
NIO
NIO
$27.35$4.13+562.2%Buy$63.53
HBP
Huttig Building Products
$8.72$1.34+550.7%N/A
SAVA
Cassava Sciences
$36.33$5.61+547.6%Buy$146.00Gap Down
APPS
Digital Turbine
$39.69$6.13+547.5%Buy$105.67Gap Down
LXU
LSB Industries
$9.69$1.50+546.0%N/AShort Interest ↓
SI
Silvergate Capital
$94.62$14.74+541.9%Buy$195.75Earnings Report
Analyst Report
Analyst Revision
Gap Down
OMI
Owens & Minor
$43.83$6.83+541.7%Buy$46.25
RRC
Range Resources
$17.62$2.77+536.1%Hold$21.13
OSTK
Overstock.com
$40.86$6.46+532.5%Buy$119.83News Coverage
AMRK
A-Mark Precious Metals
$57.42$9.21+523.5%Buy$80.50
PLL
Piedmont Lithium
$46.67$7.50+522.3%Buy$89.25Short Interest ↑
MRNA
Moderna
$160.07$25.93+517.3%Hold$247.63Analyst Report
Insider Selling
Analyst Revision
GSM
Ferroglobe
$4.94$0.80+515.7%N/A
LAC
Lithium Americas
$25.06$4.09+512.7%Buy$38.11News Coverage
Gap Down
NTLA
Intellia Therapeutics
$81.52$13.35+510.6%Buy$157.56
CYCC
Cyclacel Pharmaceuticals
$3.13$0.53+490.3%Buy$17.00
UNFI
United Natural Foods
$37.84$6.47+484.9%Hold$54.00Analyst Revision
News Coverage
Positive News
Gap Down
BXC
BlueLinx
$68.60$11.75+483.8%Buy$85.50
VERI
Veritone
$15.78$2.71+482.3%Buy$46.33Gap Down
RRD
R. R. Donnelley & Sons
$11.02$1.90+480.0%N/AShort Interest ↓
News Coverage
CZR
Caesars Entertainment
$72.17$12.71+467.8%Buy$128.87Analyst Report
Short Interest ↓
News Coverage
LOVE
Lovesac
$48.28$8.69+455.6%Buy$106.50Insider Selling
Gap Down
CAR
Avis Budget Group
$175.09$32.38+440.8%Sell$194.60Analyst Report
WISH
ContextLogic
$2.47$0.47+431.2%Hold$9.95Analyst Downgrade
Insider Selling
News Coverage
AEHR
Aehr Test Systems
$11.15$2.10+431.0%Buy$31.00Gap Down
NVAX
Novavax
$84.65$16.00+429.1%Buy$245.83Analyst Report
Gap Down
INMD
InMode
$43.01$8.24+422.3%Buy$76.25Short Interest ↓
VSTO
Vista Outdoor
$38.19$7.35+419.6%Buy$55.33Positive News
EXPI
eXp World
$24.81$4.78+419.0%Hold$58.00Insider Selling
News Coverage
OPRX
OptimizeRx
$41.97$8.35+402.6%Buy$92.00Insider Selling
TUP
Tupperware Brands
$14.32$2.85+402.5%Buy$30.00
UAN
CVR Partners
$95.11$19.00+400.6%N/A
INOD
Innodata
$5.74$1.15+399.1%N/AShort Interest ↓
RFP
Resolute Forest Products
$13.26$2.66+398.5%Buy$16.00
RMBL
RumbleON
$33.81$6.85+393.6%Buy$58.80Analyst Upgrade
News Coverage
GROW
U.S. Global Investors
$5.32$1.08+392.6%N/A
MN
Manning & Napier
$7.92$1.62+388.9%N/A
PLUG
Plug Power
$21.06$4.34+385.3%Buy$43.55Analyst Report
Analyst Revision
News Coverage
Gap Down
DXYN
The Dixie Group
$4.60$0.95+384.2%N/ANews Coverage
Gap Down
PDSB
PDS Biotechnology
$5.71$1.18+383.9%Buy$19.50
SD
SandRidge Energy
$9.95$2.06+383.0%N/AShort Interest ↓
News Coverage
CALX
Calix
$43.39$9.00+382.1%Buy$58.50Upcoming Earnings
Insider Selling
Short Interest ↑
ATLC
Atlanticus
$62.51$13.00+380.8%Buy$67.00Analyst Downgrade
SM
SM Energy
$31.36$6.57+377.3%Buy$38.89Analyst Report
Analyst Revision
Gap Down
AVNW
Aviat Networks
$28.21$6.00+370.2%Buy$49.67Short Interest ↓
News Coverage
LIVE
Live Ventures
$25.20$5.36+370.2%N/AGap Down
ZS
Zscaler
$241.94$51.95+365.7%Buy$359.65Analyst Upgrade
Analyst Revision
News Coverage
BCRX
BioCryst Pharmaceuticals
$13.78$3.00+359.3%Buy$19.82Gap Down
XPEL
XPEL
$59.24$12.91+358.9%Buy$95.00High Trading Volume
KRA
Kraton
$45.97$10.12+354.2%Hold$46.50
IDT
IDT
$34.30$7.70+345.5%N/ANews Coverage
TGH
Textainer Group
$36.70$8.25+344.8%Buy$50.00
LQDT
Liquidity Services
$17.36$3.92+342.9%Buy$31.50News Coverage
TWI
Titan International
$9.83$2.22+342.8%N/APositive News
UMC
United Microelectronics
$10.88$2.48+338.7%Buy$7.30Upcoming Earnings
Positive News
CLFD
Clearfield
$46.92$10.72+337.7%Buy$44.75Upcoming Earnings
Analyst Report
Analyst Revision
Gap Down
The market contagion stemming from the spread of coronavirus has prompted companies to pre-emptively cut top and bottom-line forecasts citing supply chain disruptions and demand uncertainties. The S&P 500 (NYSEARCA: SPY) has descended into correction territory stoking fears of an impending bear market. The Federal Reserve implemented an emergency 50-basis point rate cut on March 2, 2020, to stave off coronavirus impact on the economy. Further rate cuts of at least another 50-basis points are anticipated in their meeting later this month. The yield on 10-year Treasuries sank to all-time lows below 0.7% bolstering fears of a global recession. Investors seeking portfolio protection during this tumultuous period of stock market uncertainty should take a closer look at these three stocks.

CoreLogic Inc. (NYSE: CLGX)

The dominant real estate, mortgage, and underwriting data analytics platform provider CoreLogic, Inc. (NYSE: CLGX)is a direct beneficiary of the spike in mortgage refi activity. Revenues grew six-percent YoY in their Q4 2019 earnings report beating consensus analyst EPS estimates by 0.07-per share coming in at 0.77-per share. Core mortgage and real estate solutions were the primary growth driver. This was prior to the coronavirus epidemic. Falling yields have materialized as a consequence of the economic turmoil unleashed by the spread of COVID-19. With the anticipation of more rate cuts to follow, mortgage lenders are experiencing a surge in mortgage refinancing activity. For example, a 15-year fixed rate of 3.12-percent just five years ago can be refinanced as a 10-year loan at 2.5-percent resulting in hundreds of dollars in monthly savings. While money center banks are seeing upticks on the mortgage side, that’s being offset by narrowing margins. For this reason, investors can sidestep the financials and consider the platform provider.

Utilizing the rifle charts, CLGX is one of the rare stocks with a double bullish monthly pup formation composed of a moving average (MA) pup breakout and a stochastic mini pup breakout. This is made possible by the resilient support on the rising 5-period MA at 45.48. The trajectory targets the upper monthly Bollinger Bands (BBs) at the 55.55 Fibonacci (fib) level.

Catasys (CATS)

In an era of healthcare cost-cutting initiatives, behavioral and mental health analytics, network and treatment platform provider Catasys, Inc. (NASDAQ: CATS) has a unique business model that optimizes efficiencies for insurers, providers and patients. Utilizing big data predictive analytics, CATS identifies health plan members that meet criteria for their proprietary OnTrak solution. CATS contracts with most of the nation’s largest health insurers to transition the most at risk and costliest patients who also suffer from behavioral, mental and/or substance abuse. Discreetly enrolling them in the 52-week OnTrak solution, patients utilize telemedicine and behavioral therapy to improve health as insurers see a 50-percent drop in healthcare costs, which CATS takes a percentage of. The model is designed to trim healthcare costs while improving patient care with the outcome and evidence-based treatment versus the traditional treatment center model which relies on higher healthcare costs from rising headcounts and longer “heads on beds” model. Revenues are improving but the company has yet to turn a profit. CATS is riding the healthcare cost efficiency and evidence-based treatment narrative which will continue to gain momentum, especially in an election year. CATS monthly chart has a potential monthly pup breakout which would target the 22.00 upper monthly BBs if the stochastic can cross back up.

Realty Income (O)  

Real estate investment trusts (REITs) tend to outperform benchmark indices during recessionary periods with stable dividends that can offset share depreciation. Realty Income (NYSE: O) is one of the most stable REITs with over 6,400 commercial properties throughout the U.S, U.K. and Puerto Rico. With a 98.6-percent occupancy rate, tenants include well-known household brands like Walgreens (NYSE: WBA) , Walmart (NYSE: WMT) , FedEx (NYSE: FDX) , 7-Eleven, Dollar Tree (NYSE: DLTR) and Dollar General (NYSE: DG). The company has distributed 595 consecutive months of dividends with 105 dividend increases since its NYSE listing in 1994. The company prides itself as a monthly dividend paying REIT currently yielding 3.70-percent on trailing 12-month basis. They also have a dividend reinvestment program (DRIP) for compounding gains and better dollar-cost averaging to take advantage of market downturns. Since O is a component of the SPY, there is a positive correlation with the trajectory of the benchmark S&P 500 index. Therefore, shares will still fall with the SPY. This one makes sense for investors with a long-term bullish outlook seeking steady monthly income at better than 10-year Treasury yields.

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.